FeesSafety
Pluang+

InspireMD completes first U.S. commercial TCAR procedures with FDA-approved CGuard Prime stent system.

Market News
18 Nov 2026, 23:30 WIB
GlobeNewsWire
View Source
Bullish
InspireMD completes first U.S. commercial TCAR procedures with FDA-approved CGuard Prime stent system.

InspireMD announced the successful completion of the first U.S. commercial transcarotid artery revascularization (TCAR) procedures using its FDA-approved CGuard Prime TransCarotid Stent System. This milestone marks the return of the CGuard Prime platform to the U.S. market and expands its use in TCAR procedures, which are performed over 35,000 times annually. The stent system features proprietary MicroNet mesh technology designed to reduce complications like embolization and restenosis. InspireMD is also developing a complementary neuroprotection system, SwitchGuard, to offer a comprehensive TCAR solution. This commercial launch represents a key step in InspireMD's U.S. commercialization strategy and could improve long-term stroke prevention outcomes for patients.

InspireMD's announcement of the first U.S. commercial TCAR procedures using the FDA-approved CGuard Prime TransCarotid Stent System provides context for health sector activity. For readers following health stocks, here is Pluang's market snapshot as of Nov 19, 2026 04:02 WIB: out of 150 priced US health-sector stocks, 49 rose and 100 fell. Notable movers include SYRE at USD 101.41 (+8.10%, typical hold time 6 days), TWST at USD 113.50 (+8.05%, typical hold time 28 days, Pluang order activity 69% Sell / 31% Buy), and ELV at USD 401.98 (-7.36%, typical hold time 12 days).

More News

Alpha Tau Medical reports positive trial results ahead of earnings on Nov 19, 2026.

Alpha Tau Medical reports positive trial results ahead of earnings on Nov 19, 2026.

Alpha Tau Medical is set to report earnings on November 19, 2026, with expected losses of $0.15 per share and revenue of $125,000. The company announced positive clinical trial results from its U.S. REGAIN trial for Alpha DaRT therapy in glioblastoma...

Company Fundamentals
Bullish
54 minutes ago
Nvidia shares fall 2.9% despite strong earnings and raised revenue forecast amid leadership and regulatory concerns.

Nvidia shares fall 2.9% despite strong earnings and raised revenue forecast amid leadership and regulatory concerns.

Nvidia's stock dropped 2.9% to $150.96 after initially rising on strong quarterly results and a raised revenue forecast for fiscal 2028, projecting 75% annual growth. However, investor concerns about leadership uncertainty, including calls for former...

Neutral
1 hour ago
B&G Foods raises full-year sales and EBITDA guidance on strong volume growth and debt reduction plans

B&G Foods raises full-year sales and EBITDA guidance on strong volume growth and debt reduction plans

B&G Foods increased its full-year net sales and adjusted EBITDA guidance following a 5% volume-driven sales growth in Q3 2026. The company is expanding beyond traditional retail into food service, clubs, and private labels to utilize factory capacity...

Company Fundamentals
Bullish
1 hour ago
CoreWeave shares drop 4.13% amid strong AI demand but investor worries over debt and financing costs.

CoreWeave shares drop 4.13% amid strong AI demand but investor worries over debt and financing costs.

CoreWeave's stock fell 4.13% despite strong AI demand and Nvidia's solid earnings, as investors focus on the company's heavy debt and financing challenges. The company reported 168% revenue growth and raised its 2026 revenue forecast to $13-$13.3 bil...

Bearish
1 hour ago
Performance Food Group posts 5.5% sales growth, targets $125M procurement savings by 2028

Performance Food Group posts 5.5% sales growth, targets $125M procurement savings by 2028

Performance Food Group reported a 5.5% net sales increase in fiscal Q1 2027, driven by growth in independent restaurant orders and expanding gross profit margins. The company aims to achieve $125 million in annual procurement savings by fiscal 2028 t...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App